2024 AACR Meeting: Calidi Biotherapeutics presents data on allogeneic stem cell-based virotherapy immunotherapies.

2024 AACR Meeting: Calidi Biotherapeutics presents new data on the mechanisms of action for virotherapy-loaded stem cells in its novel immunotherapies. The company's approach, using allogeneic stem cells, is believed to differentiate its technology and offer potential for universal, off-the-shelf options for cancer patients. Data will be presented on Apr 9 at AACR in San Diego.

April 09, 2024
3 Articles

Further Reading